School of Medicine
Showing 171-180 of 2,435 Results
-
Eran Bendavid
Professor of Medicine (Primary Care and Population Health), of Health Policy, Senior Fellow at the Woods Institute for the Environment and, by courtesy, at the Freeman Spogli Institute for International Studies
Current Research and Scholarly InterestsEffect of global health policies on health of individuals in developing countries, global health, HIV and TB.
-
Roberto J. Bernardo MD, MS, ATSF
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
Current Research and Scholarly InterestsExercise hemodynamics and cardiopulmonary exercise testing
-
Allison Betof, MD, PhD, FASCO
Associate Professor of Medicine (Oncology)
BioDr. Allison Betof is an Associate Professor of Medicine (Oncology), Director of the Melanoma Program, Director of Solid Tumor Cellular Therapy, and Mark & Mary Stevens Endowed Scholar in Melanoma at Stanford University School of Medicine. Dr. Betof completed her MD and PhD at Duke University, Internal Medicine residency at Massachusetts General Hospital (Harvard University) and Medical Oncology Fellowship at Memorial Sloan Kettering Cancer Center. Dr. Betof’s laboratory focuses on understanding resistance to immune checkpoint blockade and cellular therapies for melanoma and other solid tumors. She is the Principal Investigator of clinical trials exploring novel treatments for immunotherapy-refractory melanoma and is internationally recognized for her expertise in brain/CNS metastasis and the use of novel cellular therapies. Dr. Betof has been a pioneer in the use of commercial tumor infiltrating lymphocyte (TIL) therapy for the treatment of melanoma and other solid tumors. She has received funding and awards for her clinical and translational investigative work from multiple high-profile organizations, including the American Society of Clinical Oncology (ASCO), National Institutes of Health (NIH), Melanoma Research Alliance, and Melanoma Research Foundation.
-
Krish Bhadra, MD
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Krish Bhadra is a board-certified, fellowship-trained interventional pulmonologist with Stanford Health Care and a clinical assistant professor in the Department of Medicine, Division of Pulmonary, Allergy & Critical Care Medicine, at Stanford University School of Medicine.
Dr. Bhadra specializes in advanced bronchoscopy, a procedure that uses a thin, flexible tube with a camera to examine the airways and collect tissue samples from the lungs. He focuses on image-guided and robotic techniques to evaluate lung lesions (abnormal areas of lung tissue). He was the first to perform bronchoscopy guided by digital tomosynthesis, an imaging technique that creates detailed, layered views of the lungs, and was an early adopter of cone-beam computed tomography (CT), which provides three-dimensional images to guide biopsies. His approach to patient care emphasizes careful listening, clear communication, and personalized treatment planning to help patients understand their options and make informed decisions.
Dr. Bhadra’s research focuses on making bronchoscopy more precise through advanced imaging, navigation technology, and new procedural techniques. His work includes integrating imaging with robotic bronchoscopy to guide instruments to lung lesions and improve biopsy accuracy. He also studies ways to account for changes in lung anatomy during procedures. He developed a lung-navigation ventilation protocol, a breathing strategy designed to help doctors locate and biopsy small lung lesions more accurately.
Dr. Bhadra has published research in numerous peer-reviewed journals, including the Journal of Bronchology & Interventional Pulmonology and Journal of Thoracic Disease. He has also contributed to international expert consensus recommendations on robotic-assisted bronchoscopy and frequently presents his work at national and international conferences.
Dr. Bhadra is a member of the American Association for Bronchology and Interventional Pulmonology (AABIP), the American Thoracic Society (ATS), and the Society for Advanced Bronchoscopy (SAB). -
Vivek Bhalla, MD
Associate Professor of Medicine (Nephrology)
Current Research and Scholarly InterestsDr. Bhalla's two primary research interests are in the role of the kidney in diabetes and hypertension. We use molecular, biochemical, and transgenic approaches to study: (1) mechanisms diabetic kidney disease disease including the role of the endothelium to regulate inflammation and kidney injury; and (2) regulation of tubular transport of glucose, sodium, and potassium. These latter studies have treatment implications in diabetes, kidney disease, and hypertension.
-
Sushma Bharadwaj, MD
Clinical Assistant Professor, Medicine - Blood & Marrow Transplantation
BioDr. Bharadwaj is fellowship-trained in blood and marrow transplantation, cellular therapy, hematology, and oncology. She is an instructor in the Stanford School of Medicine Department of Medicine, Division of Blood & Marrow Transplantation and Cellular Therapy.
Dr. Bharadwaj focuses her expertise on diagnosing and treating cancer in blood and bone marrow. For each patient, she develops a personalized, comprehensive, and compassionate care plan. In her diverse experience as a physician and scientist, she has served as an internal medicine doctor, hospitalist, hematologist, oncologist, and blood and marrow transplantation specialist. Dr. Bharadwaj has a degree in clinical research and is currently conducting clinical trials in transplant and cellular therapy.
She has participated in research studies of advances in therapy for chronic lymphocytic leukemia, melanoma, and breast cancer. She has co-authored articles published in Leukemia and Lymphoma and elsewhere. Topics include advances in cell transplantation. She also co-wrote the chapter on genome-driven personalized cancer therapy in the book Precision Medicine in Oncology.
Dr. Bharadwaj has made presentations at meetings of the American Society of Hematology, American Society of Clinical Oncology, and other associations.
Subjects include racial, demographic, and socioeconomic disparities in the treatment of patients with acute myeloid leukemia.
Dr. Bharadwaj is a member of the American Society for Transplantation and Cellular Therapy, American Society of Hematology, and American Society of Clinical Oncology.